Literature DB >> 25562659

Fragile X mice have robust mGluR5-dependent alterations of social behaviour in the Automated Tube Test.

C E F de Esch1, W E van den Berg2, R A M Buijsen1, I A Jaafar1, I M Nieuwenhuizen-Bakker1, F Gasparini3, S A Kushner2, R Willemsen4.   

Abstract

Fragile X syndrome is the most common monogenetic form of intellectual disability and autism. Although the Fmr1 knockout mouse model recapitulates many aspects of the human FXS condition, the establishment of robust social behavioural phenotypes suitable for drug screening has been difficult. Here, we describe a novel social behavioural paradigm, the Automated Tube Test (ATT), for which Fmr1 knockout mice demonstrate a highly reliable and robust phenotype. Fmr1 KO mice show highly dominant behaviour over wild-type littermates in the ATT. Consistent with previous findings, we observed a highly significant, albeit partial, rescue of the altered social behaviour of Fmr1 knockout mice in the ATT, using genetic (mGluR5 deletion) or pharmacological inhibition (mGluR5 antagonist) of mGluR5 signalling independently. Together, our results validate the Automated Tube Test as a robust outcome measure for social behaviour in preclinical research for FXS, and confirm the pathophysiological relevance of mGluR5 signalling. Moreover, our findings highlight the strategy of initiating pharmacological intervention in adulthood as holding significant clinical potential.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ERK; Fragile X; Glutamate receptor; Social behaviour; Tube

Mesh:

Substances:

Year:  2015        PMID: 25562659     DOI: 10.1016/j.nbd.2014.12.021

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  15 in total

1.  Enhanced Social Dominance and Altered Neuronal Excitability in the Prefrontal Cortex of Male KCC2b Mutant Mice.

Authors:  Allison M J Anacker; Jacqueline T Moran; Sara Santarelli; C Gunnar Forsberg; Tiffany D Rogers; Gregg D Stanwood; Benjamin J Hall; Eric Delpire; Jeremy Veenstra-VanderWeele; Michael D Saxe
Journal:  Autism Res       Date:  2019-04-12       Impact factor: 5.216

2.  Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome.

Authors:  Patrick K McCamphill; Laura J Stoppel; Rebecca K Senter; Michael C Lewis; Arnold J Heynen; David C Stoppel; Vinay Sridhar; Katie A Collins; Xi Shi; Jen Q Pan; Jon Madison; Jeffrey R Cottrell; Kimberly M Huber; Edward M Scolnick; Edward B Holson; Florence F Wagner; Mark F Bear
Journal:  Sci Transl Med       Date:  2020-05-20       Impact factor: 17.956

Review 3.  Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back.

Authors:  Christina Gross; Anne Hoffmann; Gary J Bassell; Elizabeth M Berry-Kravis
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

4.  Sex-specific mechanism of social hierarchy in mice.

Authors:  Wouter E van den Berg; Sander Lamballais; Steven A Kushner
Journal:  Neuropsychopharmacology       Date:  2014-12-03       Impact factor: 7.853

Review 5.  Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.

Authors:  Elizabeth M Berry-Kravis; Lothar Lindemann; Aia E Jønch; George Apostol; Mark F Bear; Randall L Carpenter; Jacqueline N Crawley; Aurore Curie; Vincent Des Portes; Farah Hossain; Fabrizio Gasparini; Baltazar Gomez-Mancilla; David Hessl; Eva Loth; Sebastian H Scharf; Paul P Wang; Florian Von Raison; Randi Hagerman; Will Spooren; Sébastien Jacquemont
Journal:  Nat Rev Drug Discov       Date:  2017-12-08       Impact factor: 84.694

6.  Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.

Authors:  Flavio H Beraldo; Valeriy G Ostapchenko; Fabiana A Caetano; Andre L S Guimaraes; Giulia D S Ferretti; Nathalie Daude; Lisa Bertram; Katiane O P C Nogueira; Jerson L Silva; David Westaway; Neil R Cashman; Vilma R Martins; Vania F Prado; Marco A M Prado
Journal:  J Biol Chem       Date:  2016-08-25       Impact factor: 5.157

7.  The non-coding RNA BC1 regulates experience-dependent structural plasticity and learning.

Authors:  Victor Briz; Leonardo Restivo; Emanuela Pasciuto; Konrad Juczewski; Valentina Mercaldo; Adrian C Lo; Pieter Baatsen; Natalia V Gounko; Antonella Borreca; Tiziana Girardi; Rossella Luca; Julie Nys; Rogier B Poorthuis; Huibert D Mansvelder; Gilberto Fisone; Martine Ammassari-Teule; Lutgarde Arckens; Patrik Krieger; Rhiannon Meredith; Claudia Bagni
Journal:  Nat Commun       Date:  2017-08-17       Impact factor: 14.919

8.  Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety.

Authors:  Tori L Schaefer; Matthew H Davenport; Lindsay M Grainger; Chandler K Robinson; Anthony T Earnheart; Melinda S Stegman; Anna L Lang; Amy A Ashworth; Gemma Molinaro; Kimberly M Huber; Craig A Erickson
Journal:  J Neurodev Disord       Date:  2017-06-12       Impact factor: 4.025

9.  Of Men and Mice: Modeling the Fragile X Syndrome.

Authors:  Regina Dahlhaus
Journal:  Front Mol Neurosci       Date:  2018-03-15       Impact factor: 5.639

10.  Paradoxical effect of baclofen on social behavior in the fragile X syndrome mouse model.

Authors:  Shimriet Zeidler; Andreea S Pop; Israa A Jaafar; Helen de Boer; Ronald A M Buijsen; Celine E F de Esch; Ingeborg Nieuwenhuizen-Bakker; Renate K Hukema; Rob Willemsen
Journal:  Brain Behav       Date:  2018-04-26       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.